LATESTNEWS
-
CDE Clears IND Application for Therapeutic Candidate Targeting ATTR
Mar 18, 2024
-
Investing in the Next Frontier of Healthcare: Navigating Opportunities in In Vivo Gene Editing Technologies
Feb 15, 2024
-
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
Dec 17, 2023
